Showing results (31-40 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|April 29, 2016
Evaluation of the Pharmacokinetic Interaction Between the β3 -Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy SubjectsWalter J J Krauwinkel, Virginie M M Kerbusch, John Meijer, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Dose Linearity of Glimepiride in Healthy Human Egyptian VolunteersSally A Helmy, Heba M El Bedaiwy, Noha O Mansour
Clinical Pharmacology in Drug Development|April 29, 2016
Glycerol Phenylbutyrate in Patients With Cirrhosis and Episodic Hepatic Encephalopathy: A Pilot Study of Safety and Effect on Venous Ammonia ConcentrationMarwan Ghabril, Igor A Zupanets, John Vierling, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Darexaban, an Oral Direct Factor Xa Inhibitor, in Healthy Elderly Japanese SubjectsTakeshi Kadokura, Keishi Oikawa, Koji Miyata, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Methotrexate Polyglutamate Monitoring in Patients With Crohn's DiseaseMonika Fischer, Shivi Siva, Gwendolyn K Cook, et al.
Clinical Pharmacology in Drug Development|July 2, 2016
Plasma Pharmacokinetics of Veledimex, a Small-Molecule Activator Ligand for a Proprietary Gene Therapy Promoter System, in Healthy SubjectsHongliang Cai, Lei Sun, John Miao, et al.
Clinical Pharmacology in Drug Development|June 9, 2016
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy AdultsAndreas H Groll, Amit Desai, David Han, et al.
Clinical Pharmacology in Drug Development|June 17, 2016
A First-in-Patient, Multicenter, Double-Blind, 2-Arm, Placebo-Controlled, Randomized Safety and Tolerability Study of a Novel Oral Drug Candidate, CTP-499, in Chronic Kidney DiseaseLuAnn Sabounjian, Philip Graham, Lijun Wu, et al.
Clinical Pharmacology in Drug Development|September 8, 2017
Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset SeizuresSoujanya Sunkaraneni, David Blum, Elizabeth Ludwig, et al.
Clinical Pharmacology in Drug Development|September 8, 2017
Safety, Tolerability, and Pharmacokinetics of Therapeutic and Supratherapeutic Doses of Tramadol Hydrochloride in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Multiple-Ascending-Dose StudyByron DeLemos, Henry M Richards, Joris Vandenbossche, et al.
Pageof 135